TABLE 5.
Association between PCPs’ characteristics and overall confidence score in genomic medicine
| Characteristics | Hong Kong (n = 151) | Shenzhen (n = 258) | ||||
|---|---|---|---|---|---|---|
| Coefficient (95% CI) | p‐value | Coefficient (95% CI) | p‐value | |||
| Graduate year (reference: Post−2010) | ||||||
| Before 2000 | 0.431 (−0.001, 0.864) | 0.051a | – | – | ||
| 2000–2010 | 0.183 (−0.256, 0.623) | 0.410 | – | – | ||
| Undergraduates training (reference: No) | ||||||
| Yes | 0.391 (0.161, 0.621) | 0.001a | 0.145 (−0.082, 0.372) | 0.210 | ||
| Postgraduate training (Reference: No) | ||||||
| Yes | 0.612 (0.223, 1.000) | 0.002a | 0.218 (−0.123, 0.594) | 0.226 | ||
| Familiar with the referral pathway for suspected and confirmed conditions (reference: No) | ||||||
| Yes | 0.131 (−0.108, 0.370) | 0.281 | 0.435 (0.156, 0.715) | 0.002a | ||
| Encountered patient cases related to genomic medicine in the past 6 months (reference: No) | ||||||
| Yes | 0.192 (−0.098, 0.482) | 0.191 | 0.231 (0.036, 0.426) | 0.021a | ||
| Sufficient time to discuss with patients at consultation (reference: No) | ||||||
| Yes | 0.328 (0.011, 0.646) | 0.043a | 0.420 (0.179, 0.661) | 0.001a | ||
| Believed there are ethical controversies with genetic testing (reference: No) | ||||||
| Yes | 0.350 (0.017, 0.683) | 0.040a | – | – | ||
| Believed there is not much evidence that genetic testing is beneficial adult diseases (reference: No) | ||||||
| Yes | – | – | 0.325 (0.055, 0.594) | 0.018a | ||
a
p < 0.05 by multivariate linear regression analysis.